Masahiro Itonaga
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 49
- Surgery top 5%
- Pediatric Hepatobiliary Diseases and Treatments 18
- Pancreatitis Pathology and Treatment 18
- Gastrointestinal disorders and treatments 10
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Gastroenterology top 5%
-
- Gallbladder and Bile Duct Disorders 35
- Gastric Cancer Management and Outcomes 8
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Masayuki KitanoYasunobu YamashitaTakashi TamuraKeiichi HatamaruTakeichi YoshidaYuki KawajiTakao MaekitaMasao Ichinose
- Cited by
- OncologySurgeryGastroenterology
- Journals
- SHILAP Revista de lepidopterología (4 papers)PLoS ONE (1 paper)Medicine (4 papers)
- Partner nations
- Japan
In The Last Decade
Masahiro Itonaga
70 papers receiving 985 citations
Peers
Comparison fields: 5 of 73
- Oncology 689
- Surgery 684
- Gastroenterology 77
- Pulmonary and Respiratory Medicine 455
- Epidemiology 182
Countries citing papers authored by Masahiro Itonaga
This map shows the geographic impact of Masahiro Itonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Itonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Itonaga more than expected).
Fields of papers citing papers by Masahiro Itonaga
This network shows the impact of papers produced by Masahiro Itonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Itonaga. The network helps show where Masahiro Itonaga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Itonaga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 18 | |
| 16 | 2019 | 41 | |
| 17 | 2017 | 9 | |
| 18 | 2017 | 5 | |
| 19 | 1988 | 5 | |
| 20 | CHOLECYSTOKININ ANTAGONISM BY BENZODIAZEPINES : A NEW APPROACH TO THE MECHANISM OF ACTION OF BENZODIAZEPINES | 1986 | 1 |
About Masahiro Itonaga
Masahiro Itonaga is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (49 papers), Gallbladder and Bile Duct Disorders (35 papers), Pediatric Hepatobiliary Diseases and Treatments (18 papers), Pancreatitis Pathology and Treatment (18 papers), Gastrointestinal disorders and treatments (10 papers), Neuroendocrine Tumor Research Advances (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). The work is most often cited by research in Oncology (689 citations), Surgery (684 citations) and Gastroenterology (77 citations). Masahiro Itonaga has collaborated with scholars based in Japan. Frequent co-authors include Masayuki Kitano, Yasunobu Yamashita, Takashi Tamura, Keiichi Hatamaru, Takeichi Yoshida, Yuki Kawaji, Takao Maekita, Masao Ichinose, Mikitaka Iguchi and Reiko Ashida. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.